Polypeptides having xylanase activity and polynucleotides thereof

US9657283B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9657283-B2
Application numberUS-201514668599-A
CountryUS
Kind codeB2
Filing dateMar 25, 2015
Priority dateFeb 12, 2004
Publication dateMay 23, 2017
Grant dateMay 23, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A nucleic acid construct comprising an isolated polynucleotide encoding a polypeptide having xylanase activity operably linked to one or more heterologous control sequences that direct production of the polypeptide in a recombinant expression host, wherein the polynucleotide is selected from the group consisting of: (a) a polynucleotide encoding a polypeptide having xylanase activity comprising an amino acid sequence having at least 95% identity to amino acids 20 to 323 of SEQ ID NO: 4; (b) a polynucleotide encoding a polypeptide having xylanase activity which hybridizes under at least high stringency conditions with (i) nucleotides 58 to 1400 of SEQ ID NO: 3, (ii) the cDNA sequence of nucleotides 58 to 1400 of SEQ ID NO: 3, or (iii) the full-length complement of (i) or (ii), wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes in 2×SSC, 0.2% SDS at 65° C.; (c) a polynucleotide encoding a polypeptide having xylanase activity comprising a polynucleotide sequence having at least 95% identity to nucleotides 58 to 1400 of SEQ ID NO: 3; (d) a polynucleotide encoding a polypeptide having xylanase activity comprising amino acids 20 to 323 of SEQ ID NO: 4; and (e) a polynucleotide encoding a polypeptide having xylanase activity comprising nucleotides 58 to 1400 of SEQ ID NO: 3. 2. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising an amino acid sequence having at least 95% identity to amino acids 20 to 323 of SEQ ID NO: 4. 3. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising an amino acid sequence having at least 97% identity to amino acids 20 to 323 of SEQ ID NO: 4. 4. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising the amino acid sequence of SEQ ID NO: 4, or a fragment thereof having xylanase activity. 5. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising the amino acid sequence of SEQ ID NO: 4. 6. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising amino acids 20 to 323 of SEQ ID NO: 4. 7. The nucleic acid construct of claim 1 , wherein the polynucleotide hybridizes under at least high stringency conditions with (i) nucleotides 58 to 1400 of SEQ ID NO: 3, (ii) the cDNA sequence of nucleotides 58 to 1400 of SEQ ID NO: 3, or (iii) the full-length complement of (i) or (ii), wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes in 2×SSC, 0.2% SDS at 65° C. 8. The nucleic acid construct of claim 7 , wherein the polynucleotide hybridizes under at least very high stringency conditions with (i) nucleotides 58 to 1400 of SEQ ID NO: 3, (ii) the cDNA sequence of nucleotides 58 to 1400 of SEQ ID NO: 3, or (iii) the full-length complement of (i) or (ii), wherein very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 μg/ml sheared and denatured salmon sperm DNA, and 50% formamide and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C. 9. The nucleic acid construct of claim 1 , wherein the polynucleotide comprises a polynucleotide sequence having at least 95% identity to nucleotides 58 to 1400 of SEQ ID NO: 3. 10. The nucleic acid construct of claim 9 , wherein the polynucleotide comprises a polynucleotide sequence having at least 97% identity to nucleotides 58 to 1400 of SEQ ID NO: 3. 11. The nucleic acid construct of claim 1 , wherein the polynucleotide comprises SEQ ID NO: 3 or nucleotides 58 to 1400 of SEQ ID NO: 3. 12. The nucleic acid construct of claim 1 , wherein the polynucleotide comprises the polynucleotide sequence contained in plasmid pJLin162 which is contained in E. coli NRRL B-30702. 13. A recombinant expression vector comprising the nucleic acid construct of claim 1 . 14. An isolated recombinant host cell comprising the nucleic acid construct of claim 1 . 15. A method for producing a polypeptide having xylanase activity comprising: (a) cultivating the recombinant host cell of claim 14 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide. 16. The nucleic acid construct of claim 1 , wherein the polynucleotide is obtained by (a) hybridizing a population of DNA under at least high stringency conditions with (i) nucleotides 58 to 1400 of SEQ ID NO: 3, (ii) the cDNA sequence of nucleotides 58 to 1400 of SEQ ID NO: 3, or (iii) the full-length complementary strand of (i) or (ii); and (b) isolating the hybridizing polynucleotide, which encodes a polypeptide having xylanase activity, wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes in 2×SSC, 0.2% SDS at 65° C. 17. The nucleic acid construct of claim 16 , wherein the polynucleotide is obtained by (a) hybridizing a population of DNA under very high stringency conditions with (i) nucleotides 58 to 1400 of SEQ ID NO: 3, (ii) the cDNA sequence of nucleotides 58 to 1400 of SEQ ID NO: 3, or (iii) the full-length complementary strand of (i) or (ii); and (b) isolating the hybridizing polynucleotide, which encodes a polypeptide having xylanase activity, wherein very high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 μg/ml sheared and denatured salmon sperm DNA, and 50% formamide and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 70° C. 18. A transgenic plant, plant part or plant cell, which has been transformed with the nucleic acid construct of claim 1 . 19. A method for producing a polypeptide having xylanase activity, comprising: (a) cultivating the transgenic plant or the plant cell of claim 18 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide. 20. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising an amino acid sequence having at least 98% identity to amino acids 20 to 323 of SEQ ID NO: 4. 21. The nucleic acid construct of claim 1 , wherein the polynucleotide encodes a polypeptide having xylanase activity comprising an amino acid sequence having at least 99% identity to amino acids 20 to 323 of SEQ ID NO: 4. 22. An isolated recombinant host cell transformed with a nucleic acid construct comprising an isolated polynucleotide encoding a polypeptide having xylanase activity operably linked to one or more control sequences that direct production of the polypeptide in the recombinant host cell, wherein the polypeptide having xylanase activity is heterologous to the recombinant host cell and wherein the polynucleotide is selected from the group consisting of: (a) a polynucleotide encoding a polypeptide having xylanase activity comprising an amino acid sequence having at least 95% identity to amino acids 20 to

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9657283B2 cover?
The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/2482. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).